benazepril hydrochloride 20 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Lotensin HCT]
RxNorm concept 898371, branded drug (sbd). Prescribable name: Lotensin HCT 20 MG / 12.5 MG Oral Tablet.
- RxCUI
- 898371
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/898371 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
BZP hydrochloride 20 MG / HCTZ 12.5 MG Oral Tablet [Lotensin HCT]; Lotensin HCT (benazepril HCl 20 MG / HCTZ 12.5 MG) Oral Tablet; Lotensin HCT 20/12.5 Oral Tablet; benazepril hydrochloride 20 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet [Lotensin HCT]
Related concepts
- hydrochlorothiazide 12.5 MG (SCDC, consists of)
- benazepril hydrochloride 20 MG (SCDC, consists of)
- benazepril hydrochloride 20 MG / hydrochlorothiazide 12.5 MG [Lotensin HCT] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Lotensin HCT (BN, has ingredient)
- benazepril hydrochloride 20 MG / hydrochlorothiazide 12.5 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00078045305
- 30698045301
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 898371 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/898371 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 898371. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.